The growth of laser eye surgery in emerging markets offers huge opportunities for Iridex, says the company’s CFO James Mackaness.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
























